ABBOTT LABORATORIES Available-for-sale Securities, Gross Unrealized Gain
ABBOTT LABORATORIES (ABT) reported Available-for-sale Securities, Gross Unrealized Gain of $40.00 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-18.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains · last filed 2011-02-18
- ABBOTT LABORATORIES available-for-sale securities, gross unrealized gain for fiscal 2010 was $40.00M, a 4.76% decline from fiscal 2009.
- ABBOTT LABORATORIES available-for-sale securities, gross unrealized gain for fiscal 2009 was $42.00M, a 23.64% decline from fiscal 2008.
- ABBOTT LABORATORIES available-for-sale securities, gross unrealized gain for fiscal 2008 was $55.00M.
| Period end | Available-for-sale Securities, Gross Unrealized Gain 12 month |
|---|---|
| 2010-12-31 | $40.00M 10-K · filed 2011-02-18 |
| 2009-12-31 | $42.00M 10-K · filed 2011-02-18 |
| 2008-12-31 | $55.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |